TNFRSF21 and angioimmunoblastic T-cell lymphoma: Intriguingly, impairment of TNFRSF21/DR6 was previously implicated in increased cellular division and reduced apoptosis rates in B-cells and T-cell malignancies, including angioimmunoblastic T-cell lymphoma, another, recurrently EBV-driven type of cancer55,56.